Episode 53

Viet Ly ยท  Taking a Biotech Company to IPO and Developing Gene Therapies for Cancer & Diabetes

Graduate of the University of Washington Foster Business School in 2000, with a Business Administration degree in finance and marketing. Viet has over twenty years of experience in investing/trading, venture capital, market forecasting, and business development. Viet helped build a gene therapy biotech company Genprex and take it to IPO on Nasdaq in 2018. Viet is passionate about the global markets, building businesses, marketing, emerging technology and biotechnology. He loves spending time with his family with three young children, having a beer with friends, watching movies, and playing contact flag football.


Links from Episode:

Listen to the podcast

Watch the interview